Home > Browse Research > Life Sciences > Biotechnology > Research & Development

Research & Development: market research reports

Research and development activities are the heart of the pharmaceutical industry’s value creation. R&D fuels the product pipeline but takes its fair share of the expense side of the balance sheet. It is estimated that bringing a successful drug to market from discovery through development to market launch costs well in excess of US$1 billion.

Bringing R&D costs and times down, therefore, means there are many opportunities to improve efficiencies, advance technological innovation, and economize and optimize.

The pharmaceutical R&D category tracks both drug pipeline reports, competitive R&D strategies, and markets important and ancillary to the research efforts themselves, including activities in the biotech and sector that impinge upon the process.

Research & Development market research reports and industry analysis

Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A 5/20/2013 \| published by: Renub Research ... grow despite continuing product recalls and safety controversies, particularly in the Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers segment. Product innovation, together with demographic structure of the world population, will play a pivotal role in the ... \| read more...	$1,600.00
Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific 5/14/2013 \| published by: GBI Research ... Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific”. The report provides in-depth analysis of the drivers and barriers that affect the global critical care market. The ... \| read more...	$3,500.00
Cancer Monoclonal Antibody Partnering Agreements - CP22012 - May2013v3 5/1/2013 \| published by: Current Partnering ... deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer monoclonal antibody partnering contract documents Top cancer monoclonal antibody deals by value The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and ... \| read more...	$1,995.00
Pre-clinical Stage Partnering Terms and Agreements in Pharma Biotech Diagnostics - CP2058 - May2013v3 5/1/2013 \| published by: Current Partnering ... report provides a detailed understanding and analysis of how and why companies enter preclinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the ... \| read more...	$2,995.00
Personalized Medicine Market Analysis 5/1/2013 \| published by: RNCOS ... per individuals. The growing research applications and identification of molecular markers towards disease predisposition and progression have led to the growth of personalized medicine. Industry players have also rapidly adopted this field and are progressing ... \| read more...	$1,200.00
Biologic Drug R&D in China - Current State and Future Development 5/1/2013 \| published by: JZMed, Inc. ... biological medicines. In the recent several years growing numbers of Chinese pharma and biopharma companies have been steadily increasing their investment in innovative drug R&D, including the discovery and development of novel biologics. The current ... \| read more...	$3,685.00
Biotechnology in the US - Industry Risk Rating Report 4/24/2013 \| published by: IBISWorld ... the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), ... \| read more...	$1,020.00
Conference Documentation: Adaptive Designs in Clinical Trials 4/8/2013 \| published by: SMI Publishing, Ltd ... and improve the overall clinical accuracy. Successful implementation of adaptive designs into a trial however requires unparalleled coordination between clinicians, trial managers, statisticians and those involved in external and internal regulation. Our expert speakers are ... \| read more...	$788.78
Pharmacogenomics Partnering Terms and Agreements 4/1/2013 \| published by: Current Partnering ... analysis of how and why companies enter pharmacogenomic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pharmacogenomic technology. ... \| read more...	$2,795.00
R&D Productivity – The State of Research and Development in the BioPharmaceutical Industry (CBRSV043) 4/1/2013 \| published by: CBR Pharma Insights, LLC ... from? Is spend decreasing? If spend is decreasing, what impact is this having on R&D? What can be done to encourage innovation in the biotech and pharmaceutical industry? Is the biotech model of R&D better ... \| read more...	$3,900.00
Competitor Analysis: Interferon 4/1/2013 \| published by: La Merie Publishing ... and of other subtypes for treatment of hepatitis B and C, other infectious diseases, cancer and multiple sclerosis, respectively. Purchase of the pdf report includes a 6-month online access to the data of the report ... \| read more...	$590.00
Biophotonics Market 4/1/2013 \| published by: Yole Developpement ... in 2012 to $36B by 2017! Emerging technologies and applications will make Biophotonics a $36B market by 2017! The biophotonics market is estimated to grow from $23B in 2012 to $36B by 2017, with strong ... \| read more...	$7,990.00
Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version) 4/1/2013 \| published by: BioInformant Worldwide, L.L.C. ... blood banks exist in nearly every developed country, as well as within several developing nations. That is a 21-fold increase (2,100%) in the companies involved in the industry, over only a seven year period. This ... \| read more...	$3,995.00
Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017 3/28/2013 \| published by: MarketsandMarkets ... are used as therapeutics. In order to improve their clinical potential, second generation recombinants are being developed, each exhibiting improved efficiency and potency depending on their applications. The global protein engineering technologies market (2012-2017) report ... \| read more...	$4,650.00
Next Generation Sequencing: Market Size, Segmentation, Growth and Trends by Provider 3/26/2013 \| published by: DeciBio ... sequencing (1-2% of the genome that actually encodes proteins) or expression profiling. NGS is the fastest growing and the most attractive segment of the $7.1B genomics space (manufacturer market). With an estimated market size of ... \| read more...	$3,000.00
Biotechnology Product Manufacturing 3/25/2013 \| published by: First Research, Inc. ... US-based Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), and Monsanto; Cangene (Canada) and ADIMMUNE (Taiwan); and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). The global biotechnology industry includes ... \| read more...	$129.00
Biotechnology in the UK - Industry Market Research Report 3/20/2013 \| published by: IBISWorld ... the industry include healthcare biotech companies, industrial biotech companies and agricultural biotech companies. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are ... \| read more...	$825.00
Global Automation and Control System Market in the Pharmaceutical and Biotech Industry 3/19/2013 \| published by: Frost & Sullivan ... market drivers and restraints, along with key trends in the technology and distribution of the automation control systems. The research service is a global study covering North America, Europe, Asia Pacific and other key emerging ... \| read more...	$7,000.00
Medical & Scientific Research (Global) - Industry Report 3/18/2013 \| published by: Plimsoll Publishing Ltd. ... QIAGEN AS and ARM LIMITED. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Medical & Scientific Research (Global) analysis is ideal for anyone wanting ... \| read more...	$1,425.00
Medical & Scientific Research (European) - Industry Report 3/18/2013 \| published by: Plimsoll Publishing Ltd. ... & DEVELOPPEMENT, NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO and CBMM EUROPE B.V.. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Medical & Scientific Research ... \| read more...	$1,200.00
Biotechnology in the US - Industry Market Research Report 3/7/2013 \| published by: IBISWorld ... increasingly aging population will drive solid revenue growth in the next five years. Furthermore, federal mandates will likely benefit the industry, causing research and development to increase over the period. Firms in this industry primarily ... \| read more...	$910.00
The Survey of Best Practices in Biological & Medical Laboratory Management 3/1/2013 \| published by: Primary Research Group ... or biotech firms and other organizations that conduct advanced biological or medical research. The study looks closely at how key lab procedures are handled, in-house or outsourced, for gene sequencing, laboratory animal management, DNA preparation ... \| read more...	$169.00
Biopharma M&A and Deal Making (CBRSV041) – Understanding the Latest Trends to Optimize Future Strategy 3/1/2013 \| published by: CBR Pharma Insights, LLC ... while struggling to deliver on pipeline potential. Externalization strategies are a key means to boost future revenues and, indeed more imminently, to satisfy shareholder demands. However, the increasing size of the leading biopharmaceutical companies is ... \| read more...	$3,900.00
Top Ten Suppliers of Synthetic Biology Technology 3/1/2013 \| published by: BCC Research ... market leadership, and commitment to this market via investment in products. When selecting these top 10 companies, BCC Research looked across the industry spectrum and selected the most active and significant contributors while recognizing that ... \| read more...	$2,550.00
Hematopoietic Stem Cell Transplantation – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... the therapeutic development for Hematopoietic Stem Cell Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hematopoietic Stem Cell Transplantation. ... \| read more...	$2,000.00

< prev 1 2 3 4 5 6 7 8 9 10 next >